The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy
- PMID: 21047873
- DOI: 10.1093/protein/gzq083
The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy
Abstract
Meganucleases (MNs) are highly specific enzymes that can induce homologous recombination in different types of cells, including mammalian cells. Consequently, these enzymes are used as scaffolds for the development of custom gene-targeting tools for gene therapy or cell-line development. Over the past 15 years, the high resolution X-ray structures of several MNs from the LAGLIDADG family have improved our understanding of their protein-DNA interaction and mechanism of DNA cleavage. By developing and utilizing high-throughput screening methods to test a large number of variant-target combinations, we have been able to re-engineer scores of I-CreI derivatives into custom enzymes that target a specific DNA sequence of interest. Such customized MNs, along with wild-type ones, have allowed for exploring a large range of biotechnological applications, including protein-expression cell-line development, genetically modified plants and animals and therapeutic applications such as targeted gene therapy as well as a novel class of antivirals.
Similar articles
-
Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases.Nature. 2008 Nov 6;456(7218):107-11. doi: 10.1038/nature07343. Nature. 2008. PMID: 18987743
-
Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets.J Mol Biol. 2006 Jan 20;355(3):443-58. doi: 10.1016/j.jmb.2005.10.065. Epub 2005 Nov 15. J Mol Biol. 2006. PMID: 16310802
-
A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences.Nucleic Acids Res. 2006;34(22):e149. doi: 10.1093/nar/gkl720. Epub 2006 Nov 27. Nucleic Acids Res. 2006. PMID: 17130168 Free PMC article.
-
Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy.Curr Gene Ther. 2007 Feb;7(1):49-66. doi: 10.2174/156652307779940216. Curr Gene Ther. 2007. PMID: 17305528 Review.
-
Targeted approaches for gene therapy and the emergence of engineered meganucleases.Expert Opin Biol Ther. 2009 Oct;9(10):1289-303. doi: 10.1517/14712590903213669. Expert Opin Biol Ther. 2009. PMID: 19689185 Review.
Cited by
-
Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol.Nat Biotechnol. 2018 Sep;36(8):717-725. doi: 10.1038/nbt.4182. Epub 2018 Jul 9. Nat Biotechnol. 2018. PMID: 29985478
-
Current status and future prospect of FSHD region gene 1.J Biosci. 2017 Jun;42(2):345-353. doi: 10.1007/s12038-017-9681-x. J Biosci. 2017. PMID: 28569257 Review.
-
Precision editing of large animal genomes.Adv Genet. 2012;80:37-97. doi: 10.1016/B978-0-12-404742-6.00002-8. Adv Genet. 2012. PMID: 23084873 Free PMC article. Review.
-
Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells.Cell. 2011 Sep 30;147(1):107-19. doi: 10.1016/j.cell.2011.07.049. Cell. 2011. PMID: 21962511 Free PMC article.
-
Nanotechnology for delivery of peptide nucleic acids (PNAs).J Control Release. 2016 Oct 28;240:302-311. doi: 10.1016/j.jconrel.2016.01.005. Epub 2016 Jan 8. J Control Release. 2016. PMID: 26776051 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
